ID
13881
Description
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC); ODM derived from: https://clinicaltrials.gov/show/NCT01482104
Link
https://clinicaltrials.gov/show/NCT01482104
Keywords
Versions (1)
- 3/13/16 3/13/16 -
Uploaded on
March 13, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Skin Neoplasms NCT01482104
Eligibility Skin Neoplasms NCT01482104
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
breastfeeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0006147
Description
gorlins syndrome
Data type
boolean
Alias
- UMLS CUI [1]
- C0004779
Description
porphyria
Data type
boolean
Alias
- UMLS CUI [1]
- C3463940
Description
xeroderma pigmentosum
Data type
boolean
Alias
- UMLS CUI [1]
- C0043346
Description
arsenic exposure
Data type
boolean
Alias
- UMLS CUI [1]
- C0238690
Description
hypersensitivity methyl 5-aminolevulinate
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C1134467
Description
concomitant treatment immunosuppressive medication
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C0021081
Description
Compliance behavior Limited Comorbidity
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Similar models
Eligibility Skin Neoplasms NCT01482104
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C1134467 (UMLS CUI [1,2])
C0021081 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
No comments